Mason Rachel E, Sappenfield Olivia R, Turyk Mary E, Caskey Rachel N, Chor Julie
Division of Epidemiology and Biostatistics, University of Illinois at Chicago School of Public Health, Chicago, Illinois.
Department of Internal Medicine, University of Illinois at Chicago, Chicago, Illinois; Department of Pediatrics, University of Illinois at Chicago, Chicago, Illinois.
J Adolesc Health. 2020 Oct;67(4):562-568. doi: 10.1016/j.jadohealth.2020.03.002. Epub 2020 May 16.
Current guidelines recommend that individuals receive their first Pap test at age 21 years and only receive a pelvic examination before age 21 years for clinical indications. We sought to determine the prevalence and associated covariates of receiving a pelvic examination or Pap test before 21 years of age.
We analyzed the 2013-2015 National Survey of Family Growth. We conducted bivariate analyses comparing individuals who had and had not had a pelvic examination or Pap test and multivariable logistic regression to identify factors associated with having a pelvic examination or Pap test under 21 years.
This study included 1,170 individuals. Of respondents, 30.8% received a pelvic examination and 25.1% received a Pap test before 21 years of age. Receiving a pelvic examination was associated with being sexually active (adjusted odds ratio [aOR]: 6.6, 95% confidence interval [CI]: 3.8-11.7), having ever taken contraceptive pills (aOR: 2.6, 95% CI: 1.6-4.1) compared with no contraceptive method, and being screened for sexually transmitted infections in the past 12 months (aOR: 12.6, 95% CI: 7.3-21.8). Receiving a Pap test was also associated being sexually active (aOR: 7.2, 95% CI: 3.7-14.0), having ever taken contraceptive pills (aOR: 3.0, 95% CI: 1.9-4.7) compared with no contraceptive method, and being screened for sexually transmitted infections in the past 12 months (aOR: 8.94, 95% CI: 5.12-15.61).
Contrary to contemporary guidelines, a notable proportion of individuals under the age of 21 years continues to receive pelvic examinations and Pap testing.
当前指南建议个体在21岁时接受首次巴氏试验，且仅在21岁之前因临床指征进行盆腔检查。我们试图确定在21岁之前接受盆腔检查或巴氏试验的患病率及相关协变量。
我们分析了2013 - 2015年全国家庭生育调查。我们进行了双变量分析，比较接受和未接受盆腔检查或巴氏试验的个体，并进行多变量逻辑回归以确定与21岁以下接受盆腔检查或巴氏试验相关的因素。
本研究纳入了1170名个体。在受访者中，30.8%在21岁之前接受了盆腔检查，25.1%在21岁之前接受了巴氏试验。接受盆腔检查与性活跃（调整后的优势比[aOR]：6.6，95%置信区间[CI]：3.8 - 11.7）、曾经服用避孕药（与未采用任何避孕方法相比，aOR：2.6，95%CI：1.6 - 4.1）以及在过去12个月内接受性传播感染筛查（aOR：12.6，95%CI：7.3 - 21.8）相关。接受巴氏试验也与性活跃（aOR：7.2，95%CI：3.7 - 14.0）、曾经服用避孕药（与未采用任何避孕方法相比，aOR：3.0，95%CI：1.9 - 4.7）以及在过去12个月内接受性传播感染筛查（aOR：8.94，95%CI：5.12 - 15.61）相关。
与当代指南相反，相当比例的21岁以下个体仍在接受盆腔检查和巴氏试验。
